Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in Santa Ana. Study-provided care at no cost to qualified participants.
Access type 2 diabetes specialists in Santa Ana at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a stable dose of semaglutide or tirzepatide. Participation in the study will last about 9 months.
Sponsor: Eli Lilly and Company
Check if you qualify for this type 2 diabetes clinical trial in Santa Ana, CA
If you're searching for type 2 diabetes treatment options in Santa Ana, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Santa Ana research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.